Literature DB >> 32387618

CXCR5/NRF2 double knockout mice develop retinal degeneration phenotype at early adult age.

Hu Huang1, Anton Lennikov2.   

Abstract

The objective of this study is to characterize the retinal degeneration (RD) phenotype of CXCR5/NRF2 double knockout (DKO) mice at the early adult age. CXCR5 KO mice and NRF2 KO mice were bred to create CXCR5/NRF2 DKO mice. The assessment of RD features included fundus and optical coherence tomography (OCT) imaging, periodic acid-Schiff (PAS), and immunofluorescence staining of retinal pigment epithelium (RPE)-choroid flatmounts. Stained samples were imaged with fluorescent microscopy, and Western blots were used to monitor protein expression changes. The staining of cleaved caspase-3 and PNA-lectin was performed to assess the presence of photoreceptor cell apoptosis. Quantification and statistical analyses were performed with Image J and Graphpad software. The young adult (2-6 months) DKO mice exhibited increased hypopigmented spots on fundus and sub-RPE abnormalities on OCT as compared to the CXCR5-KO mice, and C57BL6 WT controls. PAS-stained sections demonstrated aberrant RPE/sub-RPE depositions. The DKO mice had increased sub-RPE depositions of IgG and AMD-associated proteins (β-amyloid, Apolipoprotein-E, C5b-9, and αB-crystallin). The protein expression of AMD-associated proteins and microglia marker (TMEM119) were upregulated at the RPE/BM/choroid complex of DKO mice. The adult DKO mice underwent photoreceptor cell apoptosis compared to the single CXCR5 and NRF2 KO and the WT mice at an early adult age. Mechanistically increased expression of CXCL13 and N-cadherin was observed as a sign of epithelial-mesenchymal transition. The data suggest that the CXCR5/NRF2-DKO mice develop RD characteristics at an early age and may serve as a valuable animal model of RD.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Age-related macular degeneration; Cxcr5; Inflammation; Mouse model; Nrf2; Retinal degeneration; Retinal pigment epithelium

Mesh:

Substances:

Year:  2020        PMID: 32387618      PMCID: PMC7456539          DOI: 10.1016/j.exer.2020.108061

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  36 in total

Review 1.  An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration.

Authors:  G S Hageman; P J Luthert; N H Victor Chong; L V Johnson; D H Anderson; R F Mullins
Journal:  Prog Retin Eye Res       Date:  2001-11       Impact factor: 21.198

2.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

3.  Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema.

Authors:  Takashi Iizuka; Yukio Ishii; Ken Itoh; Takumi Kiwamoto; Toru Kimura; Yosuke Matsuno; Yuko Morishima; Ahmed E Hegab; Shinsuke Homma; Akihiro Nomura; Tohru Sakamoto; Masako Shimura; Aruto Yoshida; Masayuki Yamamoto; Kiyohisa Sekizawa
Journal:  Genes Cells       Date:  2005-12       Impact factor: 1.891

4.  Nicotine-induced oxidative stress contributes to EMT and stemness during neoplastic transformation through epigenetic modifications in human kidney epithelial cells.

Authors:  Yu-Wei Chang; Kamaleshwar P Singh
Journal:  Toxicol Appl Pharmacol       Date:  2019-04-29       Impact factor: 4.219

5.  The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes.

Authors:  Mary J Mattapallil; Eric F Wawrousek; Chi-Chao Chan; Hui Zhao; Jayeeta Roychoudhury; Thomas A Ferguson; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

Review 6.  Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma.

Authors:  Desirée Bartolini; Katiuscia Dallaglio; Pierangelo Torquato; Marta Piroddi; Francesco Galli
Journal:  Transl Res       Date:  2017-11-29       Impact factor: 7.012

7.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

8.  Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.

Authors:  Ana I Rojo; Nadia G Innamorato; Ana M Martín-Moreno; María L De Ceballos; Masayuki Yamamoto; Antonio Cuadrado
Journal:  Glia       Date:  2010-04       Impact factor: 7.452

9.  The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration.

Authors:  Jingsheng Tuo; Brena C Smith; Christine M Bojanowski; Annal D Meleth; Igal Gery; Karl G Csaky; Emily Y Chew; Chi-Chao Chan
Journal:  FASEB J       Date:  2004-06-18       Impact factor: 5.191

10.  Isolation, culture and characterization of primary mouse RPE cells.

Authors:  Rosario Fernandez-Godino; Donita L Garland; Eric A Pierce
Journal:  Nat Protoc       Date:  2016-06-09       Impact factor: 13.491

View more
  2 in total

Review 1.  Experimental Models in Neovascular Age Related Macular Degeneration.

Authors:  Olivia Rastoin; Gilles Pagès; Maeva Dufies
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

Review 2.  Targeting Lipid Metabolism for the Treatment of Age-Related Macular Degeneration: Insights from Preclinical Mouse Models.

Authors:  Michael Landowski; Catherine Bowes Rickman
Journal:  J Ocul Pharmacol Ther       Date:  2021-11-17       Impact factor: 2.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.